Listed

Abvc Biopharma, Inc.: Form 8-K, filed Mar 3, 2026

Filed with the SEC on Mar 3, 2026 and accepted by EDGAR at Mar 3, 2026, 16:14 ET.

Share

Items reported

  • Item 2.02 Results of operations
  • Item 4.02 Non-reliance on financial statements
  • Item 9.01 Financial statements and exhibits

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Source: SEC EDGAR, the filing index for accession 0001213900-26-023054. Last ingested by Listed: Nov 14, 2026, 21:07 ET. Listed shows no prices and gives no investment advice.